|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | SUITE 500 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 17933-00012
|
||||||||
|
6. House ID# 312630000
|
TYPE OF REPORT | 8. Year | 2015 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: DAVID WIERMANSKI |
Date | 7/8/2015 1:58:17 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 6 21st Century Cures Act
H.R. 282 Long-Term Studies of Comprehensive Outcomes and Returns for the Economy (Long-Term SCORE) Act
H.R. 580 Data Accountability and Trust Act
H.R. 596 To repeal the Patient Protection and Affordable Care Act and health care-related provisions in the Health Care and Education Reconciliation Act of 2010, and for other purposes
H.R. 823 Educating Tomorrows Engineers Act
H.R. 879 Ax the Tax on Middle Class Americans Health Plans Act
H.R. 880 American Research and Competitiveness Act of 2015
H.R. 928 To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act
H.R. 1234, the Medical Freedom Act of 2015
H.R. 1624 Protecting Affordable Coverage for Employees Act
H.R. 1704 Personal Data Notification and Protection Act of 2015
H.R. 1770 Data Security and Breach Notification Act of 2015
H.R. 2050 Middle Class Health Benefits Tax repeal Act
H.R. 2126 Cutting Costly Codes Act of 2015
H.R. 2300 Empowering Patients First Act
H.R. 2650 RESCUE Americas Health Care Act of 2015
H.R. 2651 Eliminating Disparities in Diabetes Prevention, Access and Care Act
H.R. 2652 Protecting Patients and Physicians Against Coding Act of 2015
H.R. 2712 Commonsense Reporting and Verification Act of 2015
S. 177 Data Security and Breach Notification Act
S. 673 Winding Down ObamaCare Act 2015
S. 961 Data Security Act of 2015
S.1027 Data Breach Notification and Punishing Cyber Criminals Act of 2015
S. 1099 Protecting Affordable Coverage for Employees (PACE) Act
S. 1101 Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act
S. 1016 Preserving Freedom and Choice in Health Care Act
S.1158 Consumer Privacy Protection Act of 2015
S. 149 Medical Device Access and Innovation Protection Act/ H.R. 160 Protect Medical Innovation Act of 2015
S. 547/H.R. 1053 Commercial Privacy Bill of Rights Act of 2015
S. 586/H.R. 1192 National Diabetes Clinical Care Commission Act
S. 620/H.R. 1189 Preserving Employee Wellness Programs Act
S. 844/H.R. 1533 The Medical Device Tax Elimination Act
S. 1137 PATENT Act/ H.R. 9 The Innovation Act
S. 1475/H.R. 2603 Saving Lives, Saving Costs Act
S. 1509/H.R. 2404 Treat and Reduce Obesity Act of 2015
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
|
Christopher |
Adamec |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2 Medicare Access and CHIP Reauthorization Act
H.R. 876 NOTICE Act
H.R. 887 Electronic Health Fairness Act
H.R. 1021 Protecting the Integrity of Medicare Act
H.R. 1117 Creating Access to Residency Education (CARE) Act of 2015
H.R. 1686 Preventing Diabetes in Medicare Act of 2015
H.R. 1726 Access to Quality Diabetes Education Act of 2015
H.R.2247 ICD-TEN Act
H.R. 2505 the Medicare Advantage Coverage Transparency Act of 2015
H.R. 2506 the Seniors Health Care Plan Protection Act of 2015
H.R. 2507 the Increasing Regulatory Fairness Act of 2015
H.R.2570 Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
H.R.2579 Securing Care for Seniors Act of 2015
H.R.2581 Preservation of Access for Seniors in Medicare Advantage Act of 2015
S. 776 Medication Therapy Management Empowerment Act
S. 804 Medicare CGM (continuous glucose monitoring) Access Act of 2015
S. 141/H.R. 1190 Protecting Seniors Access to Medicare Act of 2015
S. 314/H.R. 592 Pharmacy and Medically Underserved Areas Enhancement Act
S. 704/H.R. 2704 Community Based Independence for Seniors Act
S. 1131/H.R. 2102 Medicare Diabetes Prevention Act of 2015
S. 1148/H.R. 2124 Resident Physician Shortage Reduction Act of 2015
S. 1509/H.R. 2404 Treat and Reduce Obesity Act of 2015
S.1531/H.R. 2756, the Patient Freedom Act of 2015
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Congressional Budget Office (CBO), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Grealy |
|
|
|
Debbie |
Witchey |
|
|
|
Michael |
Freeman |
|
|
|
Tina |
Grande |
|
|
|
Amanda |
Uherek |
|
|
|
Christopher |
Adamec |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |